![]() Glaukos Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. | ||
Founding Date | Founding Date 1998 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Aliso Viejo, US HQ Buenos Aires, AR Heatherton, AU Sao Paulo, BR Richmond Hill, CA San José, CR Wiesbaden, DE see more | Locations London, GB HQ Dandenong South, AU Wien, AT Markham, CA Bogotá, CO Helsinki, FI Helsinki, FI see more |
Employees | Employees 90716% increase | Employees 2,900 |
Valuation ($) | Valuation ($) 7.6 b | Valuation ($) 2.9 b |
Financial | ||
Revenue (est.) | Revenue (est.) $507.4m (FY, 2025) | Revenue (est.) $1.4b (FY, 2025) |
Cost of goods | Cost of goods $111.8m (FY, 2025) | Cost of goods $448.2m (FY, 2025) |
Gross profit | Gross profit $282.8m (FY, 2025) | Gross profit $939.9m (FY, 2025) |
Net income | Net income ($187.7m) (FY, 2025) | Net income ($242.5m) (FY, 2025) |